Japan Ministry of Health Approves Use of Induced Pluripotent Stem Cells (iPSCs) for Spinal Injuries

 Japan Ministry of Health Approves Use of Induced Pluripotent Stem Cells (iPSCs) for Spinal Injuries

Japan Ministry of Health Approves Use of Induced Pluripotent Stem Cells (iPSCs) for Spinal Injuries


Shots:

  • The Japan Ministry of Health, Labor and Welfare approves the evaluation of iPS cells in a clinical research for spinal cord injuries at Keio University in Tokyo, with expected onset in H1’2019
  • The study is will be conducted enrolling 4 adults with spinal cord injuries whose sensation and bodily mobility have been completely lost, transplating 2M cells of iPS with the usage of immunosuppressant drugs to control transplant rejection
  • iPSCs are adult cells genetically reprogrammed to an embryonic stem cell for expressing genes & properties of embryonic stem cell. In 2014 & 2018, RIKEN Center for Developmental Biology & Kyoto University initiated trials using iPSCs for treat eye disorder & Parkinson’s disease respectively

Click here to read full press release/ article | Ref: Reuters | Image: Getty Images 

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post